Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, November 21, 2009, 1:58PM ET - U.S. Markets Closed. Dow Down 0.14% Nasdaq Down 0.50%
Medtronic, Inc. (MDT)On Nov 20: 39.62  Up 0.01 (0.03%)  
MORE ON MDT
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, MN 55432
United States - Map
Phone: 763-514-4000
Fax: 763-514-4879
Web Site: http://www.medtronic.com

DETAILS 
Index Membership:S&P 100
S&P 500
S&P 1500 Super Comp
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:41,158

BUSINESS SUMMARY 
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide. Its Cardiac Rhythm Disease Management segment offers cardiac pacemakers, implantable defibrillators, cardiac resynchronization therapy devices, atrial fibrillation products, leads, ablation products, electrophysiology catheters, information systems, diagnostics and monitoring products, and patient management tools. The company’s Spinal segment offers thoracolumbar, cervical, and interbody spinal devices; bone growth substitutes; and devices for vertebral compression fractures and spinal stenosis. Its CardioVascular segment offers coronary and peripheral stents and related delivery systems, endovascular stent graft systems, distal embolic protection systems, perfusion systems, positioning and stabilization systems, products for the repair and replacement of heart valves, and surgical ablation products, as well as balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The company’s Neuromodulation segment offers neurostimulators, implantable drug delivery systems, deep brain stimulation systems, and urology and gastroenterology devices. Its Diabetes segment offers external insulin pumps, continuous glucose monitors, carelink therapy management software, and blood glucose meters. The company’s Surgical Technologies segment offers tissue-removal systems, surgical drill systems, fluid-control products, cranial fixation devices, nerve monitoring systems, image-guided surgery systems, intra-operative imaging systems, a Ménière’s disease therapy device, and a portfolio of products to treat benign snoring and obstructive sleep apnea. Its Physio-Control segment offers external defibrillators, including manual defibrillator/monitors used by hospitals and emergency response personnel; and automated external defibrillators used in commercial and public settings. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Medtronic, Inc.


    CORPORATE GOVERNANCE 
    Medtronic, Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 62.9% of S&P 500 companies and 93.2% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. William A. Hawkins III, 54
    Chairman and Chief Exec. Officer
    $ 3.34M $ 0
    Mr. Gary L. Ellis , 51
    Chief Financial Officer, Principal Accounting Officer and Sr. VP
    $ 1.49M $ 74.00K
    Mr. H. James Dallas , 50
    Sr. VP of Quality & Operations and Member of Operating Committee
    $ 1.43M $ 0
    Mr. Jean-Luc Butel , 51
    Exec. VP and Group Pres of International
    $ 1.05M $ 0
    Mr. Scott R. Ward , 48
    Sr. VP and Pres of CardioVascular
    N/A N/A
    Dollar amounts are as of 31-Dec-09 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis